GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AIM Vaccine Co Ltd (HKSE:06660) » Definitions » Net Income Including Noncontrolling Interests

AIM Vaccine Co (HKSE:06660) Net Income Including Noncontrolling Interests : HK$-299 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is AIM Vaccine Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

AIM Vaccine Co's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2024 was HK$-142 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-299 Mil.

AIM Vaccine Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for AIM Vaccine Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AIM Vaccine Co Net Income Including Noncontrolling Interests Chart

AIM Vaccine Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial 474.66 -827.58 -257.55 -2,133.13 -297.31

AIM Vaccine Co Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only -314.44 -281.57 -1,851.56 -156.38 -142.22

AIM Vaccine Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-299 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AIM Vaccine Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of AIM Vaccine Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

AIM Vaccine Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AIM Vaccine Co Ltd (HKSE:06660) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
HKSE:02616 HKSE:06955 HKSE:01477 HKSE:02256 HKSE:02480 HKSE:02179 HKSE:01541 HKSE:02315 HKSE:01672 HKSE:01873 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
2 Ronghua South Road, 26th Floor, Building T6, Han’s Plaza, Economic Technological Development Area, Beijing, CHN
Website
https://www.aimbio.com
AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain, ranging from research and development to manufacturing and commercialization. The Vaccine products include Recombinant HBV Vaccines, Freeze-dried Human Rabies Vaccine, Inactivated HAV Vaccines, Group A, C, Y, and W135 MPSV, Bivalent Inactivated HFRS Vaccine, and Mumps Vaccine. It generates the majority of its revenues in the PRC.
Executives
Shang Hai Xun Jing Qi Ye Guan Li Zhong Xin You Xian He Huo 2201 Interest of corporation controlled by you
Xi Zang Ying Feng Shi Ye You Xian Gong Si 2101 Beneficial owner
Yang Aihua 2201 Interest of corporation controlled by you
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Shang Yin Xing Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Zi Ben Guan Li Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Shi Bei Lun Qu Guo You Zi Ben Yun Ying You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Kong Gu You Xian Gong Si 2101 Beneficial owner
Chang Wei 2201 Interest of corporation controlled by you
Wang Aijun 2201 Interest of corporation controlled by you
China Merchants Bank Co., Ltd. 2201 Interest of corporation controlled by you
Zhang Kuo 2201 Interest of corporation controlled by you
Zhang Chong 2201 Interest of corporation controlled by you

AIM Vaccine Co Headlines

No Headlines